SCHEMBL10153366

SCHEMBL10153366

O=CC=Nc1ccc(SC(F)(F)F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
PTPRZ1 P23471 4/20 0.43
PTPN1 P18031 2/20 0.43
LMNA P02545 5/20 0.42
HTT P42858 2/20 0.42
KIF11 P52732 1/20 0.36
S100B P04271 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
KCNK2 O95069 1/20 0.32
KCNK10 P57789 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
EPHX2 P34913 1/20 0.31
NR1H4 Q96RI1 1/20 0.31
MAPT P10636 2/20 0.30
TSHR P16473 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19422210 0.78 S100B (0.39) S100BSMN1; SMN2MAPT
SCHEMBL19448746 0.77 SLC6A4 (0.34) PTPRZ1PTPN1LMNAHTTSMN1; SMN2
SCHEMBL13590027 0.77 S100B (0.50) ALDH1A1KDM4ETDP1S100BSMN1; SMN2
SCHEMBL10153370 0.75 PTGS2 (0.46) ALDH1A1KDM4EKIF11S100BRAB9A
SCHEMBL14648360 0.74 ALDH1A1 (0.52) ALDH1A1KDM4ETDP1PTPRZ1PTPN1
SCHEMBL1020679 0.73 TDP1 (0.47) ALDH1A1KDM4ETDP1PTPRZ1PTPN1
SCHEMBL13590024 0.73 ESR1 (0.43) S100BMAPT
SCHEMBL19422200 0.70 S100B (0.33) S100BTSHR
SCHEMBL19422196 0.70 MAPT (0.45) ALDH1A1TDP1KIF11TRPV1SMN1; SMN2
SCHEMBL833952 0.70 ALDH1A1 (0.52) ALDH1A1KDM4ETDP1PTPRZ1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329907-B2 Autotaxin inhibitors MERCK PATENT GMBH (DE) 2012-12-11 US disclosed
US-20120015976-A1 AUTOTAXIN INHIBITORS MERCK PATENT GESELLSCHAFT MIT BESCHRANK TER HAFTUNG (DE) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015976-A1 AUTOTAXIN INHIBITORS ENPP2, PLA2G12A, LPCAT1 ALDH1A1 4088/4885KDM4E 3203/4885TDP1 1108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.